Related Experiment Videos
Exclusion of elderly persons from health-risk behavior clinical trials
Becca Levy1, Julie Kosteas, Martin Slade
1Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, CT 06520-8034, USA. becca.levy@yale.edu
Background:
It has been found that the elderly population is underrepresented in clinical trials aimed at disease treatment. It is unknown to what extent this group is also excluded from clinical trials aimed at reducing health-risk behaviors.
Method:
We systematically reviewed clinical trials targeting the leading health-risk behaviors, as identified by Healthy People 2010: tobacco use, overweight/obesity, physical inactivity, substance abuse, and irresponsible sexual behavior. Using MEDLINE, we identified clinical trials published in the five most cited medical journals between January 1990 and May 2004.
Results:
The majority (53%) of the 198 health-risk behavior clinical trials excluded persons over the age of 65; the exclusion percentage increased to 72% for those over the age of 75. The exclusion of elderly persons in these five medical journals did not decline over the 14 years studied. This age exclusion pattern was not explained by the intervention's intrusiveness or whether illness was an exclusion criterion. The trials that included those over the age of 65 were more likely to report a significant finding in the predicted direction.
Conclusions:
Although elderly persons are most at risk for diseases linked to lifestyle behavior, such as heart disease, they were excluded from the majority of health-risk behavior clinical trials in five major medical journals.
Insights
Elderly individuals are frequently excluded from clinical trials on health behaviors, despite being at higher risk for related diseases. This exclusion persisted over 14 years in major medical journals.
Area of Science:
- Public Health
- Gerontology
- Clinical Trial Design
Background:
- Elderly populations are underrepresented in disease treatment clinical trials.
- Exclusion of older adults from health-risk behavior trials is not well-documented.
Purpose of the Study:
- To determine the extent of elderly exclusion from clinical trials targeting major health-risk behaviors.
- To analyze trends in this exclusion over time.
Main Methods:
- Systematic review of clinical trials on leading health-risk behaviors (tobacco use, obesity, inactivity, substance abuse, sexual behavior).
- Searched MEDLINE for trials published in top 5 cited medical journals (1990-2004).
Main Results:
- 53% of trials excluded individuals over 65; 72% excluded those over 75.
- Exclusion rates did not decrease over the 14-year study period.
- Exclusion was not linked to intervention intrusiveness or illness criteria.
Conclusions:
- Older adults were excluded from most health-risk behavior trials in major journals.
- This exclusion occurs despite higher risks for lifestyle-related diseases in the elderly.
- Trials including older adults were more likely to yield significant findings.
Related Concept Videos
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution